Constipation, Dyssynergia
Conditions
Keywords
Fecobionics, Biofeedback therapy, Defecation
Brief summary
Constipation affects 12-19% of Americans. Pelvic floor dyssynergia is considered to play an important role in constipation but the underlying mechanisms are not well understood in individual patients. The investigators have developed a novel device named Fecobionics that provide detailed mapping of physiological parameters during defecation. The aim of the study is to use Fecobionics to assess anorectal function in dyssynergia patients and monitor and predict the outcome of the biofeedback therapy.
Detailed description
This study aims to monitor and predict biofeedback therapy based on mechanism-based and highly integrated data using a new medical device. This study is specifically for patients with dyssynergia before, during, and after biofeedback therapy. The balloon-like Fecobionics device (10 cm long and 1 cm in diameter) will be inserted into the participant's rectum and will record data before and during the expulsion of the device. The participant will be asked to do different motions like cough, squeeze, or push during the procedure. The novel data obtained in this study may help the investigators to identify the patients who will benefit or not benefit from biofeedback therapy before the therapy is done. This will determine the effectiveness of treatments for anorectal disorders.
Interventions
DEVICEFecobionics
Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry and balloon expulsion test may be used as reference. Anorectal manometry and balloon expulsive test are standard methods for anorectal functional measurement.
Sponsors
Scripps Clinic
Augusta University Medical Center
The California Medical Innovations Institute, Inc.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Subject must provide written informed consent. 2. Age between 21-75 years. 3. Subjects must fulfill the criteria for obstructed defecation/dyssynergia and enter the BFT at UCSD or Scripps.
Exclusion criteria
1. Female who is pregnant or lactating. 2. Prior abdominal or anorectal surgery or bowel resection. 3. Diagnosis of fecal incontinence, any anorectal symptoms and drug use that affect anorectal function. 4. Confirmed or suspected COVID-19 infection. 5. Severe cardiovascular disease. 6. Subjects not willing to consent and undergo the specified tests in this study. 7. Other exclusions, that in the opinion of the investigator, the volunteer is not a suitable subject for the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Expulsion Duration | 1.5 year | The time it takes to defecate Fecobionics |
| Pressure Difference between front and rear ends of Fecobionics | 1.5 year | A measure of anal sphincter pressure, the driving rectal pressure, and the difference between these two pressures. This is the key to the determination of defecation phases. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Anorectal angle | 1.5 year | Anorectal angle is an important parameter for defecation |
| Mechanical Tension of Fecobionics | 1.5 year | To reflect anorectal function, the mechanical tension will be computed. The tension is equal to anorectal radius multiply pressure. |
| Expulsion Velocity | 1.5 year | Measured from the time difference between multiple sensor data |
| Cross-sectional area | 1.5 year | Computed by diameter |
Countries
United States
Contacts
Primary ContactHans Gregersen, PhD
Backup ContactSatish Rao, MD, PhD
Outcome results
None listed